Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Evolent Health Inc (NYSE: EVH) closed the day trading at $26.34 up 0.73% from the previous closing price of $26.15. In other words, the price has increased by $0.73 from its previous closing price. On the day, 1.53 million shares were traded. EVH stock price reached its highest trading level at $27.28 during the session, while it also had its lowest trading level at $26.0.
Ratios:
For a better understanding of EVH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.29. For the most recent quarter (mrq), Quick Ratio is recorded 1.08 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on August 09, 2024, Upgraded its rating to Buy and sets its target price to $33 from $28 previously.
On April 22, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $40.
On March 01, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $45.Oppenheimer initiated its Outperform rating on March 01, 2024, with a $45 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’24 when McCarthy Daniel Joseph sold 23,693 shares for $30.89 per share. The transaction valued at 731,790 led to the insider holds 198,809 shares of the business.
McCarthy Daniel Joseph sold 10,469 shares of EVH for $339,008 on Aug 23 ’24. The PRESIDENT now owns 188,340 shares after completing the transaction at $32.38 per share. On Aug 22 ’24, another insider, Weinberg Jonathan, who serves as the General Counsel of the company, sold 42,140 shares for $31.20 each. As a result, the insider received 1,314,706 and left with 167,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 3063078656 and an Enterprise Value of 3741250560. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30 while its Price-to-Book (P/B) ratio in mrq is 2.87. Its current Enterprise Value per Revenue stands at 1.589 whereas that against EBITDA is 27.457.
Stock Price History:
Over the past 52 weeks, EVH has reached a high of $35.00, while it has fallen to a 52-week low of $17.98. The 50-Day Moving Average of the stock is -5.35%, while the 200-Day Moving Average is calculated to be -5.48%.
Shares Statistics:
Over the past 3-months, EVH traded about 2.44M shares per day on average, while over the past 10 days, EVH traded about 1917630 shares per day. A total of 113.89M shares are outstanding, with a floating share count of 110.67M. Insiders hold about 4.84% of the company’s shares, while institutions hold 112.77% stake in the company. Shares short for EVH as of 1726185600 were 14036939 with a Short Ratio of 5.75, compared to 1723680000 on 15867814. Therefore, it implies a Short% of Shares Outstanding of 14036939 and a Short% of Float of 13.74.
